CPHI Milan · 6–8 October 2026Plan a conversation
PARTNER WITH SIKALIAS

Let’s shape your next project.

CMO, CDMO, nearshoring, raw materials or quality documentation. Choose your starting point and tell us what your next decision needs.

A focused brief starts a useful conversation

What brings you to Sikalias?

CMO · Technology transfer & manufacturing

Your dossier status, dosage form, market and forecast define the first technical discussion.

For an initial discussion, a short outline is enough. Share confidential formulas, dossiers or patient information only through an agreed secure channel. A meeting request is confirmed by our team.

From the first discussion to an agreed programme

Technical fit

We review the product category, dosage form, target market, materials, packaging and expected scale.

Development & dossier route

In-development dossiers and commissioned programmes are discussed case by case. Data readiness, ownership, licensing rights, territory and the MAH role are agreed explicitly. Specialist regulatory offices may be engaged.

Commercial scope

Development or transfer work, validation, supply volumes, milestones and quotation follow the technical assessment.

Nearshoring

We assess molecule class, non-sterile dosage form, handling needs, analytical readiness and transfer route. The programme is scoped after the technical and authorisation review.

Explore the scope →